Skip to main content
2023 AANS Annual Scientific Meeting Main banner
Back
Scientific Session

Tumor
Scientific Session

(SS#I) Scientific Session I: Tumor

Saturday, April 22, 2023
1:30pm – 5:00pm PST
Location:Los Angeles Convention Center, 408B

Disclosure(s):
W. Christopher Newman, MD: No financial relationships to disclose
Kristin M. Huntoon, PhD DO: No financial relationships to disclose

Presentations:

  • 1:30pm – 1:36pm PST
    Advancing Neurosurgery Oncology Through Advocacy

    Speaker: Katie O. Orrico, JD – AANS/CNS Washington Office

  • 1:37pm – 1:43pm PST
    The AANS/CNS Section on Tumors: Advocacy over the Years

    Speaker: Isabelle Germano, MD, MBA – Icahn School of Medicine at Mount Sinai

  • 1:44pm – 1:53pm PST
    Health Policy Development: the AANS/CNS Washington Committee
  • 1:54pm – 2:03pm PST
    The Neurosurgeon's Role in Brain Tumor Advocacy Organizations

    Speaker: Susan C. Pannullo, MD – New York Presbyterian Hospital/ Weill Cornell Medicine

  • 2:04pm – 2:13pm PST
    NIH, Academia and Patient Advocate Collaboration: The Path Forward in Brain Tumors

    Speaker: Desmond A. Brown, MD, PhD – Surgical National Institutes of Health

  • 2:14pm – 2:23pm PST
    Decreasing Barriers to Enrollment in Clinical Trials

    Speaker: Michael Vogelbaum, MD, PhD – Moffitt Cancer Center

  • 2:24pm – 2:33pm PST
    Strategies to Promote a Diverse Faculty Workforce

    Speaker: Nduka Amankulor, MD – University of Pennsylvania Health System

  • 2:34pm – 2:38pm PST
    Introduction to Ronald L. Bittner Lecture

    Speaker: Isabelle Germano, MD, MBA – Icahn School of Medicine at Mount Sinai

  • 2:39pm – 2:59pm PST
    Ronald L. Bittner Lecture

    Speaker: Gelareh Zadeh, MD, PhD, FRCSC, FAANS – University Health Network

  • 3:30pm – 3:34pm PST
    American Brain Tumor Association Young Investigator Award: Route of Administration and Antigen Specificity Drive Response to Toll-like Receptor-based Vaccination for Intracranial Melanoma Tumors

    Presenting Author: Pavan Shah, BS – Johns Hopkins University School of Medicine

  • 3:35pm – 3:39pm PST
    Gladiator Project Award (2023 Award Winner): Unique Tissue-based Analysis Following Convection-enhanced Delivery of Topotecan Reveals Individualized Mechanisms of Response and Resistance

    Presenting Author: Michael G. Argenziano, BA (he/him/his) – Columbia University Vagelos College of Physicians and Surgeons

  • 3:40pm – 3:44pm PST
    Stryker CNS Tumor Award (2023 Award Winner): Next Generation Sequencing-derived Genomic Subclasses Predict the Impact of Extent of Resection in IDH Wild-type Glioblastoma

    Presenting Author: Arka N. Mallela, MD, MS (he/him/his) – University of Pittsburgh

  • 3:45pm – 3:49pm PST
    Integra Foundation Award (2023 Winner): Factors Affecting Willingness to Participate in Therapeutic Clinical Trials for Minority Patients with Low and High-grade Gliomas

    Presenting Author: Mulki Mehari – University of California, San Francisco (UCSF)

  • 3:50pm – 3:54pm PST
    Rosenblum-Mahaley Clinical Research award (2023 Award Winner): GRASP Dynamic Contrast-enhanced MRI Can Assist in Distinguishing Brain Metastasis Progression from Radiation Effects After Stereotactic Radiosurgery

    Presenting Author: Assaf Berger, MD – NYU Langone Health

  • 3:55pm – 3:59pm PST
    Elekta Tumor Section Award (2023 Award Winner): Amine Chemical Exchange Saturation Transfer Echo Planar Imaging (CEST-EPI) Visualizes Infiltrating Glioblastoma Cells and Prognosticates Progression Free Survival in New and Recurrent Glioblastoma

    Presenting Author: Kunal S. Patel, MD – University of California, Los Angeles

  • 4:00pm – 4:04pm PST
    Journal of Neuro-oncology Award (2023 Award Winner): Targeting Retrograde Trafficking Pathways to Overcome Chemoresistance in Glioblastoma

    Presenting Author: Shreya Budhiraja (she/her/hers) – Northwestern University Feinberg School of Medicine

  • 4:05pm – 4:09pm PST
    Brain Network Connectivity in Patients with Primary and Secondary Brain Tumors: Machine Learning Analysis of Large-scale Networks

    Presenting Author: Alexis A. Morell, MD – Jackson Memorial Hospital

  • 4:10pm – 4:14pm PST
    AANS/CNS Joint Section on Tumors Neuro-oncology Trainee Award (2023 Award Winner): RAGE Inhibitor (TTP488) as an Alternative To dexamethasone For managing Cerebral Edema Following Brain Tumor Surgery

    Presenting Author: Mojtaba Dayyani, MD (he/him/his) – Division of Neurosurgery, City of Hope Beckman Research Institute and Medical Center, Duarte, California, United States.

  • 4:15pm – 4:20pm PST
    Controversies in Management of Brain Metastases: Surgery Remains the Standard of Care

    Speaker: Aaron Cohen-Gadol, MD – Indiana University/The Neurosurgical Atlas

  • 4:21pm – 4:27pm PST
    Controversies in Management of Brain Metastases: Radiosurgery Remains the Standard of Care

    Speaker: Veronica Chiang, MD, FAANS – Yale University School of Medicine

  • 4:28pm – 4:34pm PST
    Controversies in Management of Brain Metastases: Targeted Therapy Remains the Standard of Care

    Speaker: Peter Fecci, MD, PhD (he/him/his) – Duke University Medical Center

  • 4:35pm – 5:00pm PST
    Controversies in Management of Brain Metastases: Case Discussion

    Panelist: Aaron Cohen-Gadol, MD – Indiana University/The Neurosurgical Atlas

    Panelist: Peter Fecci, MD, PhD (he/him/his) – Duke University Medical Center

    Panelist: Veronica Chiang, MD, FAANS – Yale University School of Medicine